A small imaging trial could reshape how brain metastases are detected and Radiopharm Theranostics is betting on it (ASX: RAD)
Seeing Machines (AIM: SEE) reports 33% royalty growth and 4.8 million cars on road as GSR countdown intensifies
ImmuPharma (AIM: IMM) advances P140 patent and partnering push with new study data and peer-review manuscript in preparation
Read More 2 minute read General business news Tata Consultancy Services to enhance Teachers’ Pension Scheme experience Tata Consultancy Services (TCS) announced its selection by the UK Department for Education (DfE) to administer and improve… byPallavi MadhirajuJune 6, 2023